Arrowhead Pharmaceuticals Aktie

Kaufen
Verkaufen
24,91 EUR +0,01 EUR +0,04 %
26,60 USD +0,27 USD +1,03 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 3,08 Mrd. EUR

Div. Rendite 0,00%

WKN A2AGYB

ISIN US04280A1007

Symbol ARWR


Arrowhead Pharmaceuticals Aktie Analyse

07.09.18 Arrowhead Pharmaceuticals Buy B. Riley FBR
06.09.18 Arrowhead Pharmaceuticals Buy Chardan Capital Markets
08.08.18 Arrowhead Pharmaceuticals Overweight Cantor Fitzgerald
02.07.18 Arrowhead Pharmaceuticals Buy Chardan Capital Markets
09.05.18 Arrowhead Pharmaceuticals Overweight Cantor Fitzgerald
12.02.18 Arrowhead Pharmaceuticals Neutral Cantor Fitzgerald
12.02.18 Arrowhead Pharmaceuticals Neutral B. Riley FBR, Inc.
05.01.18 Arrowhead Pharmaceuticals Neutral B. Riley FBR, Inc.
30.11.16 Arrowhead Pharmaceuticals Mkt Perform William Blair
30.11.16 Arrowhead Pharmaceuticals Hold Cantor Fitzgerald
30.11.16 Arrowhead Pharmaceuticals Neutral Chardan Capital Markets
10.11.16 Arrowhead Pharmaceuticals Buy Chardan Capital Markets
19.05.16 Arrowhead Pharmaceuticals Buy Chardan Capital Markets
09.10.14 Arrowhead Pharmaceuticals Sector Perform RBC Capital Markets